Your browser doesn't support javascript.
loading
Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic: Lessons learned.
Khawaja, Fareed; Srinivasan, Krithika; Spallone, Amy; Feldman, Adina; Cantu, Sherry; Ariza-Heredia, Ella; Dvordak, Tanya; Alousi, Amin; Ahmed, Sairah; George, Marina; Frenzel, Elizabeth; Bhatti, Micah; Chemaly, Roy F.
  • Khawaja F; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Srinivasan K; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Spallone A; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Feldman A; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Cantu S; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ariza-Heredia E; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Dvordak T; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Alousi A; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • George M; Office of Chief Operating Officer, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Frenzel E; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Bhatti M; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Chemaly RF; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX; Office of Chief Operating Officer, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: rfchemaly@mdanderson.org.
Am J Infect Control ; 51(5): 506-513, 2023 05.
Article en En | MEDLINE | ID: mdl-35901993

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infección Hospitalaria / COVID-19 / Neoplasias Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infección Hospitalaria / COVID-19 / Neoplasias Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article